Glenmede Trust Company »

Vaxxinity Cl A Ord shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of Vaxxinity Cl A Ord (VAXX) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in Vaxxinity Cl A Ord

Tip: Access up to 7 years of quarterly data

All positions including Vaxxinity Cl A Ord held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxxinity Cl A Ord by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $14k 19k 0.72

More positions owned by Glenmede Trust Company

Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds Small Cp Etf (VB)
Home Depot (HD)
Procter & Gamble Company (PG)
Accenture Plc Ireland Shs Class A (ACN)

View all positions for Glenmede Trust Company

Top funds holding Vaxxinity Cl A Ord

Adage Capital Partners GP
BlackRock
Vanguard Group
Geode Capital Management
State Street Corporation
Northern Trust
Creative Planning
Bridgeway Capital Management
Pathstone Holdings
Stelac Advisory Services
Charles Schwab Investment Management
Bank of New York Mellon
Bank of America Corporation
Ieq Capital
McAdam

View all funds holding Vaxxinity Cl A Ord